EP2310041
Title:
UNACYLATED GHRELIN AND ANALOGS AS THERAPEUTIC AGENTS FOR VASCULAR REMODELING IN DIABETIC PATIENTS AND TREATMENT OF CARDIOVASCULAR DISEASE
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic Information
Publication number:
EP2310041
WO Application Number:
EP2009057263
Type:
European Patent Granted for NL
Status:
Deemed not to be granted
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP09761776.5
WO Publication Number:
WO2009150214
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
France (FR)
Publications:
Dates
Filing date:
12/06/2009
Grant date:
13/02/2013
EP Publication Date:
13/02/2013
WO Publication Date:
Claims Translations Received Date:
Claims Translation B1 Received Date:
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
13/02/2013
EP B1 Publication Date:
13/02/2013
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
11/06/2029
Lapsed By Expiration Date:
Revocation Date:
Invalidity Date:
13/02/2013
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:
Applicant/holder
From:
13/02/2013
Name:
ALIZE PHARMA
Address:
15, Chemin Du Saquin, Espace Europeen, 69130 ECULLY, France (FR)